Dre Greenlaw Release: Market Interest from Five Teams vs. 2025 Availability
The Denver Broncos’ decision to cut linebacker Dre Greenlaw after one season sits alongside explicit interest from multiple teams, including the New York Giants, Philadelphia Eagles, Green Bay Packers, San Francisco 49ers and Buffalo Bills. The comparison answers one question: does that prospective market outweigh Greenlaw’s limited 2025 availability because of injuries and a suspension?
Dre Greenlaw: release after one season and just eight games in 2025
Ian Rapoport said the Broncos are releasing linebacker Dre Greenlaw after only one season with the franchise. Greenlaw appeared in just eight games in 2025, a total the context links directly to injuries and a suspension. The account in the context calls the past few years “rough” for Greenlaw and notes he “just can’t seem to stay on the field. ” Still, the same context says that when healthy he is a high-energy player who provides a jolt to a defense.
Giants, Eagles, Packers, 49ers, Bills: explicit teams that could pursue Greenlaw
The context lists the New York Giants, Philadelphia Eagles, Green Bay Packers, San Francisco 49ers and Buffalo Bills as potential suitors for Greenlaw in free agency. Philadelphia and Green Bay each lost a starting linebacker to the Las Vegas Raiders on the same day, with Nakobe Dean and Quay Walker headed to the Raiders; the context states those two will man the middle of the Raiders’ defense. The Giants have already signed Tremaine Edmunds but “could still make some moves” at linebacker, and the context says New York, San Francisco and Buffalo also have needs at the position and could pursue Greenlaw.
Nakobe Dean and Quay Walker moves versus Greenlaw’s availability and fit
Apply the same criteria—availability, positional need, and immediate impact—to both sides. On availability, Greenlaw played eight games in 2025 because of injuries and a suspension. On team need, Philadelphia and Green Bay lost starters Nakobe Dean and Quay Walker, creating clear openings; the context presents those moves as reasons those NFC clubs “could try to sign Greenlaw. ” On immediate impact, the context frames Greenlaw as a high-energy, physical presence when healthy, but it also emphasizes recent durability concerns. The same evaluative lens shows a trade-off: teams with acute linebacker need face a short-term gamble if they sign Greenlaw, while Greenlaw’s market exists precisely because multiple teams lack depth at the position.
Comparing the factors side by side reveals a consistent pattern in the context: demand for veteran linebacker help is high among the listed teams, yet Greenlaw’s recent availability is the primary obstacle. The context cites the specific roster moves of Nakobe Dean and Quay Walker to explain why Philadelphia and Green Bay, in particular, might pursue him. At the same time, the context explicitly says Greenlaw “should still have a solid market in free agency, ” even as it points to his limited 2025 game count as a counterweight.
Finding: The comparison establishes that while multiple teams are likely to show interest, Dre Greenlaw’s recent injuries and suspension make him a moderate-risk signing rather than a straightforward upgrade. The next confirmed event that will test this finding is Greenlaw finding a new home in 2026; that move will reveal whether teams prioritize immediate need over availability risk. If Greenlaw stays healthy and available, the comparison suggests teams that lost starters—specifically Philadelphia and Green Bay—are most likely to convert interest into a roster contract, and he could have the opportunity to revive his career.
